As expected, the IGF-1 cut-off for diagnosis of HS measured by CLIA is lower (746 ng/mL) than the RIA cut-off of 1000 ng/mL used in previous studies [1,7]. This evidence concerns the gene IGF1 and histiocytic sarcoma.